1. Home
  2. MYI vs DNA Comparison

MYI vs DNA Comparison

Compare MYI & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniYield Quality Fund III Inc

MYI

Blackrock MuniYield Quality Fund III Inc

N/A

Current Price

$10.30

Market Cap

728.5M

Sector

Finance

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

N/A

Current Price

$11.35

Market Cap

835.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYI
DNA
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
728.5M
835.7M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MYI
DNA
Price
$10.30
$11.35
Analyst Decision
Sell
Analyst Count
0
3
Target Price
N/A
★ $8.00
AVG Volume (30 Days)
1.2M
★ 2.6M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 46.49
EPS
★ N/A
N/A
Revenue
N/A
★ $170,155,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.05
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.37
$5.37
52 Week High
$11.46
$18.22

Technical Indicators

Market Signals
Indicator
MYI
DNA
Relative Strength Index (RSI) 65.63 51.79
Support Level $9.94 $6.75
Resistance Level $11.11 $13.97
Average True Range (ATR) 0.12 1.26
MACD 0.06 -0.11
Stochastic Oscillator 96.67 41.15

Price Performance

Historical Comparison
MYI
DNA

About MYI Blackrock MuniYield Quality Fund III Inc

BLACKROCK MUNIYIELD QUALITY FUND III, INC. is an investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes, as is consistent with its investment policies and prudent investment management. The fund invests a majority of its assets in municipal obligations exempt from U.S. federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax). Under normal market conditions, the fund invests mainly in long-term municipal obligations that are investment-grade quality or are considered by the adviser to be of comparable quality at the time of investment. It can also invest directly in such securities or synthetically through the use of derivatives.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: